(NEW YORK)Shares of Vertex Pharmaceuticals Inc. fell Monday after Schering-Plough Corp. reported positive data from a trial of a hepatitis C drug, showing it could be a strong competitor to ...READ MORE
Among the stock activity stories for Monday, May 19, from AP Financial News: NEW YORK (AP) _ Shares of MasTec Inc. surged on Monday after an analyst said the industrial contractor ...READ MORE
(NEW YORK)Shares of InterMune Inc. rose Monday after the Food and Drug Administration gave the biotechnology company's developing lung disease treatment fast-track status, allowing for a...READ MORE
(BRISBANE, Calif.)Biotechnology company InterMune Inc. said Thursday its first-quarter loss widened on lower revenue from its immune-system disorder drug Actimmune. The company lost $26.3 million, o...READ MORE
(NEW YORK)Shares in Vertex Pharmaceuticals Inc. slid Wednesday while Idenix Pharmaceuticals Inc. gained ground on a mix of study data for the their developing hepatitis C drug candidates.READ MORE
Among the stock activity stories for Tuesday, April 1, from AP Financial News:
NEW YORK (AP) Shares of Progenics Pharmaceutical Inc. rose Tuesday after the company said its Relis...READ MORE
(NEW YORK)
Stocks that were moving substantially or trading heavily Tuesday on the New York Stock Exchange and Nasdaq Stock Market:
NYSE
UBS AG, up $3.98 at $32.78 (UBS)
Chairman Marcel O...READ MORE